BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28720492)

  • 21. Maternal fetal transmission of Trypanosoma cruzi: a problem of public health little studied in Mexico.
    Cardoso EJ; Valdéz GC; Campos AC; de la Luz Sanchez R; Mendoza CR; Hernández AP; Ramírez MH; Habana JR; González EB; Matzumura PD; Carlier Y
    Exp Parasitol; 2012 Aug; 131(4):425-32. PubMed ID: 22683499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Seroprevalence and vertical transmission of Chagas disease in a cohort of Latin-american pregnant women in a tertiary hospital in Madrid].
    Francisco-González L; Gastañaga-Holguera T; Jiménez Montero B; Daoud Pérez Z; Illán Ramos M; Merino Amador P; Herráiz Martínez MÁ; Ramos Amador JT
    An Pediatr (Engl Ed); 2018 Mar; 88(3):122-126. PubMed ID: 28411096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pregnancy and Chagas Disease: Benznidazole's Impact on Pregnancy and Newborns: A Report of Four Cases.
    Vázquez C; García-Vázquez E; Carrilero B; Simón M; Franco F; Iborra MA; Gil-Gallardo LJ; Segovia M
    Am J Trop Med Hyg; 2020 May; 102(5):1075-1077. PubMed ID: 32207404
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chagas Disease: Implementation of Screening to Benefit Mother and Infant.
    Edwards MS; Montgomery SP
    Clin Perinatol; 2021 Jun; 48(2):331-342. PubMed ID: 34030817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicity of nifurtimox as second-line treatment after benznidazole intolerance in patients with chronic Chagas disease: when available options fail.
    Crespillo-Andújar C; Chamorro-Tojeiro S; Norman F; Monge-Maillo B; López-Vélez R; Pérez-Molina JA
    Clin Microbiol Infect; 2018 Dec; 24(12):1344.e1-1344.e4. PubMed ID: 29906591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mother-to-child transmission of congenital Chagas disease, Japan.
    Imai K; Maeda T; Sayama Y; Mikita K; Fujikura Y; Misawa K; Nagumo M; Iwata O; Ono T; Kurane I; Miyahira Y; Kawana A; Miura S
    Emerg Infect Dis; 2014 Jan; 20(1):146-8. PubMed ID: 24378113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the immune response after treatment with benznidazole versus no treatment in patients with chronic indeterminate Chagas disease.
    Vallejo A; Monge-Maillo B; Gutiérrez C; Norman FF; López-Vélez R; Pérez-Molina JA
    Acta Trop; 2016 Dec; 164():117-124. PubMed ID: 27619190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody drop in newborns congenitally infected by Trypanosoma cruzi treated with benznidazole.
    Chippaux JP; Clavijo AN; Santalla JA; Postigo JR; Schneider D; Brutus L
    Trop Med Int Health; 2010 Jan; 15(1):87-93. PubMed ID: 19968839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Longitudinal follow up of serological response in children treated for Chagas disease.
    Moscatelli G; Moroni S; García Bournissen F; González N; Ballering G; Schijman A; Corral R; Bisio M; Freilij H; Altcheh J
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007668. PubMed ID: 31465522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Congenital transmission of Chagas disease in a non-endemic area, is an early diagnosis possible?
    Francisco-González L; Rubio-San-Simón A; González-Tomé MI; Manzanares Á; Epalza C; Santos MDM; Gastañaga T; Merino P; Ramos-Amador JT
    PLoS One; 2019; 14(7):e0218491. PubMed ID: 31291269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations.
    Garcia S; Ramos CO; Senra JF; Vilas-Boas F; Rodrigues MM; Campos-de-Carvalho AC; Ribeiro-Dos-Santos R; Soares MB
    Antimicrob Agents Chemother; 2005 Apr; 49(4):1521-8. PubMed ID: 15793134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial.
    Viotti R; Vigliano C; Lococo B; Bertocchi G; Petti M; Alvarez MG; Postan M; Armenti A
    Ann Intern Med; 2006 May; 144(10):724-34. PubMed ID: 16702588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors and consequences of congenital Chagas disease in Yacuiba, south Bolivia.
    Salas NA; Cot M; Schneider D; Mendoza B; Santalla JA; Postigo J; Chippaux JP; Brutus L
    Trop Med Int Health; 2007 Dec; 12(12):1498-505. PubMed ID: 18076558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endemic level of congenital Trypanosoma cruzi infection in the areas of maternal residence and the development of congenital Chagas disease in Bolivia].
    Torrico F; Alonso-Vega C; Suarez E; Rodríguez P; Torrico MC; Dramaix M; Truyens C; Carlier Y
    Rev Soc Bras Med Trop; 2005; 38 Suppl 2():17-20. PubMed ID: 16482806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital transmission of Trypanosoma cruzi in central Brazil. A study of 1,211 individuals born to infected mothers.
    Luquetti AO; Tavares SB; Siriano Lda R; Oliveira RA; Campos DE; de Morais CA; de Oliveira EC
    Mem Inst Oswaldo Cruz; 2015 May; 110(3):369-76. PubMed ID: 25993506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN; Bisio M; Rocco DM; Altcheh J; Solana ME; García-Bournissen F
    Exp Parasitol; 2018 Mar; 186():50-58. PubMed ID: 29448038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mother-child transmission of Chagas disease: could coinfection with human immunodeficiency virus increase the risk?
    Scapellato PG; Bottaro EG; Rodríguez-Brieschke MT
    Rev Soc Bras Med Trop; 2009; 42(2):107-9. PubMed ID: 19448923
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug Discovery for Paediatric Chagas Disease.
    Thota S; Morel CM
    Mini Rev Med Chem; 2018; 18(9):776-780. PubMed ID: 26202205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease.
    Burgos JM; Altcheh J; Bisio M; Duffy T; Valadares HM; Seidenstein ME; Piccinali R; Freitas JM; Levin MJ; Macchi L; Macedo AM; Freilij H; Schijman AG
    Int J Parasitol; 2007 Oct; 37(12):1319-27. PubMed ID: 17570369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital Chagas disease in a non-endemic area: Results from a control programme in Bergamo province, Northern Italy.
    Rodari P; Angheben A; Gennati G; Trezzi L; Bargiggia G; Maino M; Ruggeri M; Rampello S; Soavi L; Rizzi M
    Travel Med Infect Dis; 2018; 25():31-34. PubMed ID: 29680285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.